Frederik J. van Dalen

Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.

Frank Vermeer, Maarten L. Simoons, C. de Zwaan et al. · Heart · 1988 · 60 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +8

Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris

M.DEN VAN BRAND, C. van Halem, F.DEN VAN BRINK et al. · European Heart Journal · 1990 · 34 citations · Full text

Medicine, Cardiology, Surgery +6

Diagnostic criteria and adjudication process both determine published event-rates: The ACTION trial experience

Bridget‐Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer et al. · Contemporary Clinical Trials · 2007 · 25 citations

Law, Psychology, Clinical Epidemiology +14

Usefulness of pimobendan in the treatment of heart failure.

Dirk J. Duncker, Frederik J. van Dalen, J. M. Hartog et al. · PubMed · 1986 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +17

Quality management of a large randomized double-blind multi-centre trial: The ACTION experience

Bridget‐Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer et al. · Contemporary Clinical Trials · 2007 · 10 citations

Public Health, Quality Management, Healthcare Quality Improvement +8